Carboxylic acid esters
Medchemexpress LLC Ethynodiol diacetate | 297-76-7 | 99.9% | 1 ML
Ethynodiol diacetate is a click chemistry reagent that contains an Alkyne group. It can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Features and benefits:
- Contains an alkyne group
- Undergoes copper-catalyzed azide-alkyne cycloaddition (CuAAc)
- Reacts with molecules containing azide groups
Medchemexpress LLC NB-598 (Maleate) | 155294-62-5 | 99.4% | 565.74 | 50 MG
NB-598 Maleate is a potent and competitive inhibitor of squalene epoxidase (SE), and it suppresses triglyceride biosynthesis through the farnesol pathway. It is also a click chemistry reagent, containing an Alkyne group, which allows it to undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules that contain Azide groups.
- Potent and competitive inhibitor of squalene epoxidase (SE)
- Suppresses triglyceride biosynthesis through the farnesol pathway
- Functions as a click chemistry reagent
- Contains an Alkyne group
- Capable of undergoing copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide groups
Medchemexpress LLC NB-598 Maleate | 155294-62-5 | 99.4% | 565.74 | 2 MG
NB-598 Maleate is a potent and competitive inhibitor of squalene epoxidase (SE) that suppresses triglyceride biosynthesis through the farnesol pathway. It also functions as a click chemistry reagent, containing an Alkyne group.
- Potent and competitive inhibitor of squalene epoxidase (SE)
- Suppresses triglyceride biosynthesis through the farnesol pathway
- Click chemistry reagent containing an alkyne group
- Undergoes copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing azide groups
Medchemexpress LLC Cipralisant maleate 50mg | 223420-20-0 | 50MG
Cipralisant (GT-2331) (maleate) is an orally active low-toxicity potent selective high affinity histamine H3 receptor full antagonist in vivo and an agonist in vitro with a pKi of 9 9 for histamine H3 receptor and a Ki of 0 47 nM for rat histamine H3 receptor Cipralisant (maleate) has the potential for attention-deficit hyperactivity disorder research[1 [2 [3 [4 Cipralisant (maleate) is a click chemistry reagent it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups
Medchemexpress LLC Omigapil maleate | 200189-97-5 | 99.8% | 391.42 | 5 MG
Omigapil maleate (CGP3466B) is an orally active GAPDH nitrosylation inhibitor with potential for research into Alzheimer's disease and congenital muscular dystrophy (CMD). It is also an apoptosis inhibitor and a click chemistry reagent.
- Abrogates Aβ1-42-induced tau acetylation, memory impairment, and locomotor dysfunction in mice
- Acts as an apoptosis inhibitor
- Can be used for research of congenital muscular dystrophy (CMD)
- Functions as a click chemistry reagent containing an Alkyne group
- Enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups
Medchemexpress LLC Omigapil maleate | 200189-97-5 | 99.84% | 391.42 | 1 ML
Omigapil maleate (CGP3466B) is an orally active GAPDH nitrosylation inhibitor. It has been shown to abrogate Aβ1-42-induced tau acetylation, memory impairment, and locomotor dysfunction in mice. This compound holds potential for research in Alzheimer's disease and congenital muscular dystrophy (CMD), and it also acts as an apoptosis inhibitor. Additionally, Omigapil maleate is a click chemistry reagent, possessing an Alkyne group that can participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
- Orally active GAPDH nitrosylation inhibitor
- Aβ1-42-induced tau acetylation, memory impairment, and locomotor dysfunction abrogator
- Potential for Alzheimer's disease research
- Apoptosis inhibitor
- Can be used for congenital muscular dystrophy (CMD) research
- Click chemistry reagent with an Alkyne group for CuAAc reactions